data_2ver_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ver _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.753 0.311 . . . . 2.1600000000000001 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.56 169.98 23.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.748 -0.464 . . . . 1.8799999999999999 109.748 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 94.02 0.56 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.26 0.35 . . . . 1.3500000000000001 110.439 179.75 -67.354 -128.217 110.158 103.009 2.028 103.876 43.455 -98.896 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -103.51 121.92 43.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.012 0.434 . . . . 1.8 110.496 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -111.99 122.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.792 . . . . 1.05 108.86 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 -91.85 103.91 16.4 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.468 -0.493 . . . . 4.6399999999999997 111.45 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 t -99.7 128.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.489 -0.93 . . . . 1.3999999999999999 108.489 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.6 150.48 19.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.381 -0.914 . . . . 1.3100000000000001 113.663 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.39 149.92 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.705 -0.479 . . . . 2.1400000000000001 109.705 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mt -154.8 126.88 7.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.116 0.484 . . . . 3.0099999999999998 112.041 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.3 m -114.78 120.72 41.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.618 -0.882 . . . . 2.1899999999999999 108.618 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.14 150.82 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.943 0.401 . . . . 2.2200000000000002 110.981 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -96.8 112.48 24.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.287 -0.87 . . . . 1.99 110.277 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HZ3' ' HB ' ' A' ' 25' ' ' ILE . 11.6 pttt -158.66 156.01 29.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 3.5099999999999998 110.595 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.75 164.47 13.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.891 -0.595 . . . . 2.0299999999999998 110.724 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 107' ' ' THR . 35.9 mtp180 -76.44 -12.29 60.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 1.53 110.068 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.25 -18.1 63.32 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.619 -0.719 . . . . 1.7 112.146 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -72.4 -18.97 61.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 1.8600000000000001 109.185 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' HB3' ' CG1' ' A' ' 100' ' ' VAL . 3.7 mm? -81.95 73.01 9.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.09 -0.959 . . . . 1.53 110.619 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 t -87.55 95.23 9.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.881 -0.6 . . . . 1.8700000000000001 110.322 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 t70 60.23 -95.71 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.558 -0.747 . . . . 1.55 110.099 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.42 95.11 5.36 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.248 0.547 . . . . 1.55 109.944 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.19 107.17 27.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.476 -0.784 . . . . 1.77 109.828 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.41 98.76 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.636 1.557 . . . . 1.6499999999999999 111.236 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' HB ' ' HZ3' ' A' ' 14' ' ' LYS . 5.1 pt -90.29 72.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 1.6899999999999999 111.539 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.08 116.29 3.99 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.749 -0.738 . . . . 1.5800000000000001 112.385 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.526 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 48.0 Cg_endo -88.29 115.93 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.628 2.218 . . . . 2.0800000000000001 112.09 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.61 112.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 1.48 110.605 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 96.42 2.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 1.9299999999999999 110.379 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.75 133.89 57.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.681 0.753 . . . . 1.9199999999999999 111.692 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -126.03 141.02 52.14 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.901 -1.045 . . . . 3.0800000000000001 108.871 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.72 127.38 53.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.902 0.382 . . . . 1.5900000000000001 111.26 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.2 125.56 36.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.661 -0.699 . . . . 2.8900000000000001 109.367 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.35 -147.16 19.94 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.747 -0.739 . . . . 1.45 111.651 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.2 m 56.27 63.2 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.489 . . . . 1.3999999999999999 111.266 -179.732 -98.896 43.455 110.158 103.876 2.028 103.009 -128.217 -67.354 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.61 -30.44 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.139 0.495 . . . . 2.0699999999999998 109.839 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.31 13.64 5.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.698 -0.683 . . . . 1.9299999999999999 110.963 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 tpp180 -114.9 155.0 27.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.312 -0.404 . . . . 2.0299999999999998 110.03 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.61 132.54 34.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 1.76 110.912 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.85 135.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.869 -0.789 . . . . 1.23 108.869 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB1' ' NZ ' ' A' ' 43' ' ' LYS . . . -141.43 151.39 43.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.281 0.845 . . . . 0.85999999999999999 113.281 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.85 130.28 56.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.977 -1.01 . . . . 1.01 109.123 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' NZ ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -134.72 137.83 43.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.87 109.896 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.06 152.43 25.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.884 0.373 . . . . 0.87 111.029 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.22 158.64 5.13 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.592 -0.731 . . . . 1.21 110.273 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -61.41 -19.86 62.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.394 0.516 . . . . 1.5700000000000001 112.394 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.06 -15.68 55.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.047 0.451 . . . . 1.6299999999999999 110.2 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -121.84 7.94 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.52 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.571 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 62.7 t80 -136.73 118.62 15.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.411 -0.359 . . . . 1.0900000000000001 110.105 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.19 143.5 36.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.507 . . . . 1.6899999999999999 110.344 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 54.86 35.15 23.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.989 0.423 . . . . 1.8100000000000001 111.756 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.571 ' HA3' ' CZ ' ' A' ' 49' ' ' PHE . . . 68.48 30.7 73.24 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 1.0700000000000001 113.018 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 81' ' ' ASN . 40.2 mmtm -135.97 142.65 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.212 -0.292 . . . . 1.6100000000000001 110.212 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.69 138.06 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.81999999999999995 110.714 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -154.1 164.72 38.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.259 0.552 . . . . 1.25 111.616 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -104.84 145.74 29.96 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.326 -0.99 . . . . 1.5 108.326 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' CG1' ' HA ' ' A' ' 61' ' ' ASN . 8.6 tp -127.4 152.53 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.402 -0.363 . . . . 1.6699999999999999 110.999 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -93.51 -178.78 4.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 1.47 110.457 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.13 -32.52 73.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 2.2000000000000002 111.878 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.4 -4.2 59.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 3.2999999999999998 111.625 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HA ' ' CG1' ' A' ' 57' ' ' ILE . 46.5 m-80 57.63 27.47 14.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.824 0.675 . . . . 2.2999999999999998 112.824 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -102.9 -43.57 5.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.912 0.387 . . . . 4.7400000000000002 110.718 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -86.09 113.93 22.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.63 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -116.42 122.58 45.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 2.21 109.857 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD12 ' OE1' ' A' ' 104' ' ' GLN . 36.9 tp -127.53 135.83 50.88 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.025 -0.27 . . . . 1.72 110.704 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -92.48 132.86 36.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 2.1099999999999999 110.469 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.53 136.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.603 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.49 131.07 50.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.491 . . . . 1.8999999999999999 110.578 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.71 111.56 23.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.55 -0.908 . . . . 1.6599999999999999 108.55 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 38.7 mtp180 -123.99 159.49 56.21 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.699 -0.228 . . . . 2.46 110.825 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.11 146.97 53.27 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.266 1.977 . . . . 1.3200000000000001 111.017 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.526 ' SD ' ' HB3' ' A' ' 27' ' ' PRO . 4.6 ttt -76.98 60.76 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 2.1299999999999999 110.184 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.71 35.98 26.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.217 -0.901 . . . . 2.1200000000000001 111.105 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.26 -35.55 9.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.709 -0.678 . . . . 2.4399999999999999 111.536 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.401 ' CB ' ' HE1' ' A' ' 92' ' ' TRP . 24.2 m -154.25 -178.94 7.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.54 0.21 . . . . 1.53 110.928 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.62 117.22 33.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 1.71 110.607 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -119.05 144.59 46.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 1.0600000000000001 110.535 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.7 m -74.4 122.75 23.47 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 109.603 -0.518 . . . . 1.5 109.603 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' CE2' ' A' ' 84' ' ' PHE . 15.3 t -84.17 128.03 34.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.166 -0.924 . . . . 1.4199999999999999 112.434 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 21.2 t70 -137.45 146.61 44.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.802 -1.09 . . . . 1.1799999999999999 108.52 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -75.7 2.57 11.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.587 0.232 . . . . 1.6599999999999999 111.422 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.4 -53.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.566 -0.826 . . . . 1.0 112.996 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 41.9 t -127.41 121.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 1.46 110.653 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -93.37 130.94 38.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 1.53 109.456 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' HB3' ' CB ' ' A' ' 41' ' ' ALA . 36.8 p90 -153.23 149.33 27.85 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 119.916 -0.713 . . . . 1.46 112.146 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -95.71 143.24 27.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 1.8500000000000001 110.813 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -27.63 42.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 2.6699999999999999 110.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.75 131.04 45.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.748 -0.66 . . . . 2.2799999999999998 110.913 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.8 m -81.27 164.07 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.321 -0.4 . . . . 2.2200000000000002 110.722 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.47 159.55 27.99 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.882 -0.675 . . . . 1.6100000000000001 111.608 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 170.74 1.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.167 0.508 . . . . 1.8 111.133 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.401 ' HE1' ' CB ' ' A' ' 75' ' ' SER . 6.2 t90 -137.43 142.7 41.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.492 -0.322 . . . . 1.3799999999999999 110.608 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.18 96.46 0.17 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.423 -0.671 . . . . 1.5 111.423 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.85 -150.68 5.81 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.097 -1.049 . . . . 1.1799999999999999 112.549 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.21 129.95 52.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.588 0.232 . . . . 1.6599999999999999 110.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 pt -108.89 154.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.977 -0.379 . . . . 1.21 109.977 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.62 157.71 24.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.941 -0.647 . . . . 1.0 111.535 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -93.86 121.05 44.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.601 -0.518 . . . . 1.3999999999999999 109.601 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 70' ' ' ARG . 84.0 m-85 -117.25 136.39 53.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.897 -0.409 . . . . 1.25 109.897 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 19' ' ' LEU . 6.2 p -81.86 144.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.909 0.385 . . . . 1.3100000000000001 111.294 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.05 100.75 13.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.378 -0.971 . . . . 1.26 108.378 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.2 136.04 1.53 Allowed Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.305 -0.718 . . . . 1.3500000000000001 111.305 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 130.04 42.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 2.04 110.464 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.497 ' OE1' HD12 ' A' ' 65' ' ' LEU . 23.0 tp60 -82.67 -14.6 54.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 1.9399999999999999 112.699 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.13 20.87 10.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.194 0.521 . . . . 2.0099999999999998 110.734 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.3 t30 57.41 52.61 8.42 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.46 -0.791 . . . . 2.1000000000000001 112.674 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.502 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 3.2 m -64.06 133.11 95.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.183 -0.673 . . . . 2.7599999999999998 109.183 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -32.82 103.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.273 3.315 . . . . 1.98 114.009 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.605 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 98.3 Cg_endo -89.98 -164.39 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.125 2.55 . . . . 1.74 113.327 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.57 -92.34 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.804 -0.918 . . . . 1.6399999999999999 110.804 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.89 115.63 10.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.529 -0.545 . . . . 1.8200000000000001 109.529 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 109' ' ' PRO . 50.2 m-85 -124.98 129.73 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 1.47 110.489 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -113.04 125.6 54.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.294 -0.412 . . . . 1.3500000000000001 110.076 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.4 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.3 OUTLIER -129.48 106.89 9.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.229 0.537 . . . . 1.3400000000000001 110.101 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -85.55 118.28 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 1.3500000000000001 110.971 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.8 mt -111.87 127.38 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.503 -0.554 . . . . 0.97999999999999998 109.503 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -116.07 133.76 55.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.16 0.505 . . . . 1.27 110.881 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.17 162.27 27.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.591 -0.814 . . . . 0.90000000000000002 112.093 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.42 -156.5 27.02 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.818 -0.913 . . . . 0.95999999999999996 110.818 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -113.0 172.93 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.176 -0.609 . . . . 1.6100000000000001 111.359 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.54 ' CH2' ' HA ' ' A' ' 127' ' ' GLN . 18.4 t-105 -133.0 146.68 51.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.211 -0.904 . . . . 1.1499999999999999 109.648 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -117.77 131.94 56.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.816 0.341 . . . . 1.49 111.47 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 tttm 58.61 -118.12 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.43 -0.805 . . . . 1.8200000000000001 111.597 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' HA ' ' HE1' ' A' ' 121' ' ' TRP . 3.2 p-10 -175.18 150.08 1.13 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.398 0.279 . . . . 1.4399999999999999 110.392 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 65.0 -36.86 0.21 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.337 1.236 . . . . 1.46 114.337 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 124' ' ' ASP . 62.2 pttt -64.25 -13.72 51.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 1.8600000000000001 112.873 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.54 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 31.4 mt-30 69.05 39.6 1.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.006 0.431 . . . . 1.5800000000000001 112.002 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.49 69.81 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 1.21 110.834 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -105.84 145.87 30.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.061 0.458 . . . . 1.0800000000000001 111.656 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.3 m -137.82 116.8 9.89 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 1.4199999999999999 109.813 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.49 105.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.591 2.194 . . . . 1.3600000000000001 112.615 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.81 124.73 42.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.73 -0.668 . . . . 1.25 110.622 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.73 -126.52 5.52 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.633 -0.794 . . . . 1.24 112.141 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 146.33 42.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.774 0.321 . . . . 1.5800000000000001 110.86 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 t -103.66 136.56 43.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.637 -0.875 . . . . 1.46 108.637 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.5 116.6 3.84 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.678 -0.772 . . . . 1.03 112.255 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.39 108.65 20.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.722 -0.473 . . . . 1.3400000000000001 109.722 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.4 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 8.2 m -92.34 125.59 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.469 -0.567 . . . . 1.3200000000000001 109.469 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -108.76 125.38 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.994 -0.548 . . . . 1.6399999999999999 110.442 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 53.0 tp -102.18 108.61 20.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.375 -0.83 . . . . 1.6599999999999999 108.965 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 3.4 m -117.92 134.05 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.419 . . . . 1.77 110.472 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.2 126.13 44.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.112 0.482 . . . . 1.96 110.113 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.4 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 5.9 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.73 -0.652 . . . . 2.1899999999999999 109.841 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 1' ' ' LYS . . . . . . . . . . . . . 30.0 ttpp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.103 -0.332 . . . . 3.4500000000000002 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 2' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.47 122.48 9.8 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.555 0.534 . . . . 2.2799999999999998 109.828 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 3' ' ' THR . . . . . . . . . . . . . 10.0 m -119.11 131.11 55.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.826 0.346 . . . . 2.71 111.818 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 4' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 127.06 64.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.305 -0.628 . . . . 2.3300000000000001 109.305 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.16 145.54 49.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.009 0.433 . . . . 2.9399999999999999 110.317 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.5 120.62 42.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.892 -0.595 . . . . 2.7200000000000002 110.187 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -128.28 114.52 19.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.993 0.425 . . . . 2.8500000000000001 110.492 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.54 166.45 72.75 Favored 'Cis proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.449 -1.479 . . . . 3.21 112.307 -0.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -77.59 -36.72 51.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.4 -0.593 . . . . 3.6899999999999999 109.4 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -104.24 93.3 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.284 -0.871 . . . . 4.0700000000000003 109.189 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' N' ' 106' ' ' VAL . 0.7 OUTLIER -91.57 151.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.196 -0.456 . . . . 3.4100000000000001 110.762 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' N' N ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 150.22 26.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.375 -0.375 . . . . 3.8700000000000001 110.29 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 13' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.72 116.39 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.115 -0.493 . . . . 4.04 110.774 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 13.26 18.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.016 -0.612 . . . . 3.5099999999999998 112.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -125.88 -172.72 2.67 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.908 -0.172 . . . . 4.0 110.709 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.21 154.61 36.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 2.8799999999999999 111.367 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 p -127.77 135.05 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.643 -0.503 . . . . 2.54 109.643 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -105.48 111.78 24.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.969 0.414 . . . . 2.2999999999999998 110.701 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 19' ' ' LEU . . . . . . . . . . . . . 58.0 mt -87.98 91.92 8.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.573 -0.899 . . . . 2.2400000000000002 108.573 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 20' ' ' LEU . . . . . . . . . . . . . 51.5 mt -78.11 136.04 37.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 2.3900000000000001 111.738 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.55 124.44 60.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.423 -0.808 . . . . 1.8100000000000001 110.227 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 22' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -113.04 147.38 37.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.387 -0.37 . . . . 2.5899999999999999 110.878 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m120 64.45 55.55 1.36 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.01 0.819 . . . . 2.77 111.69 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 24' ' ' LEU . . . . . . . . . . . . . 17.9 tp -77.8 130.6 72.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 2.0499999999999998 110.22 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.6 -170.56 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.951 2.434 . . . . 2.1699999999999999 113.232 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -109.01 179.87 4.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.858 -0.61 . . . . 2.6299999999999999 111.021 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 46.99 15.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.027 -0.533 . . . . 3.6299999999999999 110.904 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 28' ' ' LEU . . . . . 0.429 HD23 ' H ' ' N' ' 28' ' ' LEU . 2.2 mm? -71.55 126.37 29.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 2.6899999999999999 111.263 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -105.76 -35.25 7.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.961 -0.563 . . . . 2.8900000000000001 109.536 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.91 143.81 4.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.862 -0.685 . . . . 1.48 112.35 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 31' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -97.72 143.52 28.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.761 -0.829 . . . . 1.45 108.761 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 32' ' ' SER . . . . . . . . . . . . . 46.8 m -138.92 118.52 13.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.732 -0.387 . . . . 1.4399999999999999 111.114 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 33' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -98.67 130.47 45.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.129 -0.487 . . . . 1.52 110.089 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -122.24 155.25 36.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 1.6799999999999999 110.488 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -96.81 98.92 10.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.949 -0.389 . . . . 2.6899999999999999 109.949 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 -155.35 26.27 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.978 -0.63 . . . . 2.1200000000000001 111.848 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -116.4 9.22 14.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.661 0.23 . . . . 2.8599999999999999 111.55 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -146.34 170.34 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 6.3099999999999996 111.04 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 p -85.66 89.29 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.092 -0.504 . . . . 2.27 111.341 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.83 -155.89 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 2.7000000000000002 109.994 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.9 -32.13 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.115 -0.794 . . . . 2.3300000000000001 111.115 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 42' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.78 -16.91 34.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.313 0.577 . . . . 3.0099999999999998 109.799 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 m -115.27 41.13 2.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 2.4300000000000002 111.299 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.87 143.89 30.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 2.4500000000000002 110.484 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 45' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' N' ' 61' ' ' TYR . 76.6 mt -93.21 -54.98 6.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.64 -0.504 . . . . 1.8200000000000001 109.64 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -164.18 148.14 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.162 -0.615 . . . . 1.6499999999999999 112.464 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.5 134.56 10.4 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.373 -1.091 . . . . 1.3200000000000001 110.373 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 48' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -129.46 112.76 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.438 0.533 . . . . 1.8 112.438 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 49' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.4 105.32 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.515 -0.92 . . . . 1.9399999999999999 108.515 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 50' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -46.89 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.135 0.791 . . . . 1.98 113.135 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 51' ' ' GLY . . . . . . . . . . . . . . . -44.19 -44.06 7.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.907 0.723 . . . . 2.3100000000000001 114.907 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.84 7.37 10.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.211 0.505 . . . . 2.8300000000000001 111.526 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 59.79 26.32 15.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.414 0.626 . . . . 3.3500000000000001 110.021 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.94 102.37 8.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.285 -0.87 . . . . 1.8799999999999999 110.534 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.3 129.46 53.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.646 0.26 . . . . 1.78 110.334 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.12 126.22 25.62 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.533 -0.303 . . . . 2.1800000000000002 110.301 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 146.72 45.56 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.767 2.312 . . . . 1.96 112.896 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.62 -177.77 24.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.98 -0.628 . . . . 1.6899999999999999 111.627 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 59' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.64 -28.85 77.19 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.803 2.336 . . . . 2.0 112.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.0 8.96 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 1.9099999999999999 111.885 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 61' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' N' ' 45' ' ' ILE . 86.5 t80 -74.66 116.4 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.95 -0.389 . . . . 2.1499999999999999 109.95 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 62' ' ' SER . . . . . . . . . . . . . 34.4 p -91.37 -32.02 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 2.3900000000000001 111.138 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.16 9.58 17.64 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.766 -0.731 . . . . 2.29 111.792 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' N' ' 75' ' ' ILE . 24.1 mtm180 -112.33 -1.11 15.2 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.458 -0.571 . . . . 2.5899999999999999 109.458 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.11 116.9 25.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.072 -0.967 . . . . 1.8500000000000001 111.82 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 66' ' ' ILE . . . . . . . . . . . . . 42.7 mt -112.57 114.09 46.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.5 -0.773 . . . . 2.4700000000000002 109.125 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -97.42 142.35 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.128 0.49 . . . . 1.6399999999999999 111.393 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 68' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.81 160.24 37.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 2.1699999999999999 110.276 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 69' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.78 -14.08 30.02 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.945 2.43 . . . . 1.8300000000000001 113.281 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -94.63 13.7 23.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 1.8799999999999999 110.293 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 71' ' ' ALA . . . . . . . . . . . . . . . 73.66 -4.3 2.27 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.064 0.946 . . . . 1.55 113.349 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -70.99 145.21 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.807 0.336 . . . . 1.7 110.737 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.39 121.91 38.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.362 0.601 . . . . 1.77 111.896 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.5 114.97 29.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.303 -0.628 . . . . 2.46 109.303 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 75' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' N' ' 64' ' ' ARG . 17.5 mt -107.11 119.24 56.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.976 -0.379 . . . . 2.3300000000000001 109.976 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 76' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -96.9 167.62 10.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.212 -0.449 . . . . 3.6800000000000002 110.68 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.24 53.05 12.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.423 0.63 . . . . 3.21 110.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 78' ' ' ILE . . . . . . . . . . . . . 27.2 mm -65.41 132.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.413 -0.812 . . . . 3.1000000000000001 111.505 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 pt -112.68 179.3 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.599 -0.728 . . . . 3.3500000000000001 110.166 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -68.51 -29.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.798 0.332 . . . . 3.8799999999999999 111.679 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 81' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -74.47 -6.25 47.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 3.1699999999999999 111.624 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -81.52 -19.46 42.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 2.8999999999999999 110.561 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 83' ' ' THR . . . . . . . . . . . . . 12.0 m -59.47 116.63 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.815 -0.63 . . . . 3.5099999999999998 110.368 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.45 -154.06 25.17 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.774 -1.203 . . . . 2.8799999999999999 113.206 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -109.2 148.98 30.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.23 0.538 . . . . 3.25 111.636 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 86' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.6 141.62 50.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.205 -0.907 . . . . 2.2400000000000002 108.599 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 53.6 m -123.52 137.7 54.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.235 0.54 . . . . 1.96 112.308 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 88' ' ' LEU . . . . . . . . . . . . . 23.8 tp -113.27 135.57 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.461 -0.791 . . . . 1.55 110.583 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 89' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -113.82 122.12 46.08 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.992 -1.114 . . . . 2.1600000000000001 107.992 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 90' ' ' VAL . . . . . 0.737 ' O ' ' HA ' ' N' ' 97' ' ' ASN . 42.1 t -98.73 90.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.139 -0.624 . . . . 1.8999999999999999 110.994 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 mm -67.92 117.06 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.814 -0.63 . . . . 1.72 109.733 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 92' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' N' ' 94' ' ' ASP . 46.5 mtpt -121.36 153.02 38.33 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.507 -0.769 . . . . 2.4700000000000002 109.907 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.05 34.95 0.25 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 2.6400000000000001 110.782 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 94' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' N' ' 95' ' ' LEU . 4.2 t70 -141.4 19.3 2.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.943 -0.571 . . . . 3.1000000000000001 110.604 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 95' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' N' ' 94' ' ' ASP . 50.7 mt 73.91 -38.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.387 0.675 . . . . 3.8199999999999998 112.496 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 96' ' ' VAL . . . . . 0.407 HG11 ' HG3' ' N' ' 98' ' ' GLU . 12.2 t -69.46 93.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 2.8900000000000001 110.052 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 97' ' ' ASN . . . . . 0.737 ' HA ' ' O ' ' N' ' 90' ' ' VAL . 81.8 m-20 -97.44 40.81 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.787 -0.642 . . . . 2.2200000000000002 112.111 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 98' ' ' GLU . . . . . 0.407 ' HG3' HG11 ' N' ' 96' ' ' VAL . 13.6 mt-10 -12.82 116.65 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.295 1.438 . . . . 2.3500000000000001 114.375 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -103.3 143.65 32.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.25 -0.886 . . . . 2.3199999999999998 111.108 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.53 149.16 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 2.0800000000000001 110.007 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 101' ' ' THR . . . . . . . . . . . . . 36.3 m -126.48 136.48 52.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.083 0.468 . . . . 2.4500000000000002 111.849 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.79 171.79 20.21 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.058 -1.217 . . . . 2.3700000000000001 110.058 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.96 159.56 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.112 0.956 . . . . 3.52 111.879 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 104' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.33 164.47 38.55 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.649 -0.705 . . . . 2.9300000000000002 109.745 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 105' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -124.87 149.57 47.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 4.0800000000000001 110.9 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 106' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' N' ' 11' ' ' VAL . 13.8 t -118.93 139.65 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 3.6699999999999999 111.081 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 107' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.11 147.62 67.02 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 4.54 110.167 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.98 149.74 20.32 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.602 2.201 . . . . 4.5099999999999998 112.488 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -117.44 137.63 52.38 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.719 -0.475 . . . . 4.5300000000000002 109.719 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.16 -0.924 . . . . 5.1500000000000004 110.149 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N 1111 ' ' MTN . . . . . 0.484 ' H92' ' SD ' ' A' ' 72' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N 1112 ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N 1113 ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.753 0.311 . . . . 2.16 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.56 169.98 23.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.748 -0.464 . . . . 1.88 109.748 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 94.02 0.56 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.26 0.35 . . . . 1.33 110.439 179.75 -67.354 -128.217 110.158 103.009 2.028 103.876 43.455 -98.896 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -103.51 121.92 43.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.012 0.434 . . . . 1.68 110.496 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -111.99 122.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.792 . . . . 1.03 108.86 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 -91.85 103.91 16.4 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.468 -0.493 . . . . 4.04 111.45 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 t -99.7 128.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.489 -0.93 . . . . 1.12 108.489 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.6 150.48 19.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.381 -0.914 . . . . 1.19 113.663 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.39 149.92 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.705 -0.479 . . . . 2.14 109.705 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mt -154.8 126.88 7.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.116 0.484 . . . . 2.53 112.041 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.3 m -114.78 120.72 41.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.618 -0.882 . . . . 1.91 108.618 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.14 150.82 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.943 0.401 . . . . 1.8 110.981 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -96.8 112.48 24.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.287 -0.87 . . . . 1.62 110.277 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 25' ' ' ILE . 11.6 pttt -158.66 156.01 29.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 3.14 110.595 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.75 164.47 13.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.891 -0.595 . . . . 1.79 110.724 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 107' ' ' THR . 35.9 mtp180 -76.44 -12.29 60.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 1.5 110.068 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.25 -18.1 63.32 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.619 -0.719 . . . . 1.66 112.146 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -72.4 -18.97 61.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 1.79 109.185 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 100' ' ' VAL . 3.7 mm? -81.95 73.01 9.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.09 -0.959 . . . . 1.42 110.619 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 t -87.55 95.23 9.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.881 -0.6 . . . . 1.72 110.322 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 t70 60.23 -95.71 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.558 -0.747 . . . . 1.52 110.099 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.42 95.11 5.36 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.248 0.547 . . . . 1.38 109.944 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.19 107.17 27.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.476 -0.784 . . . . 1.36 109.828 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.41 98.76 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.636 1.557 . . . . 1.41 111.236 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.445 HD12 ' HE3' ' A' ' 14' ' ' LYS . 5.1 pt -90.29 72.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 1.55 111.539 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.08 116.29 3.99 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.749 -0.738 . . . . 1.43 112.385 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.534 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 48.0 Cg_endo -88.29 115.93 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.628 2.218 . . . . 1.78 112.09 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.61 112.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 1.02 110.605 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 96.42 2.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 1.5 110.379 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.75 133.89 57.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.681 0.753 . . . . 1.39 111.692 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -126.03 141.02 52.14 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.901 -1.045 . . . . 2.47 108.871 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.72 127.38 53.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.902 0.382 . . . . 1.26 111.26 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.2 125.56 36.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.661 -0.699 . . . . 2.39 109.367 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.35 -147.16 19.94 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.747 -0.739 . . . . 1.39 111.651 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.2 m 56.27 63.2 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.489 . . . . 1.38 111.266 -179.732 -98.896 43.455 110.158 103.876 2.028 103.009 -128.217 -67.354 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.61 -30.44 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.139 0.495 . . . . 1.95 109.839 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.31 13.64 5.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.698 -0.683 . . . . 1.72 110.963 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 tpp180 -114.9 155.0 27.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.312 -0.404 . . . . 1.86 110.03 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.61 132.54 34.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 1.5 110.912 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.85 135.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.869 -0.789 . . . . 1.01 108.869 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -141.43 151.39 43.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.281 0.845 . . . . 0.79 113.281 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.85 130.28 56.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.977 -1.01 . . . . 0.7 109.123 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 137.83 43.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.83 109.896 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.06 152.43 25.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.884 0.373 . . . . 0.8 111.029 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.22 158.64 5.13 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.592 -0.731 . . . . 1.21 110.273 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -61.41 -19.86 62.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.394 0.516 . . . . 1.29 112.394 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.06 -15.68 55.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.047 0.451 . . . . 1.63 110.2 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 114' ' ' LEU . 16.0 m120 -121.84 7.94 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.556 -0.747 . . . . 0.99 110.52 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 62.7 t80 -136.73 118.62 15.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.411 -0.359 . . . . 1.09 110.105 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.19 143.5 36.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.507 . . . . 1.69 110.344 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 54.86 35.15 23.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.989 0.423 . . . . 1.66 111.756 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . 68.48 30.7 73.24 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 1.05 113.018 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 40.2 mmtm -135.97 142.65 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.212 -0.292 . . . . 1.25 110.212 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.69 138.06 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.76 110.714 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -154.1 164.72 38.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.259 0.552 . . . . 1.16 111.616 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.2 pp -104.84 145.74 29.96 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG1' ' HA ' ' A' ' 61' ' ' ASN . 8.6 tp -127.4 152.53 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.402 -0.363 . . . . 1.3 110.999 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -178.78 4.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 1.42 110.457 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.13 -32.52 73.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 2.2 111.878 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.4 -4.2 59.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 2.81 111.625 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' CG1' ' A' ' 57' ' ' ILE . 46.5 m-80 57.63 27.47 14.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.824 0.675 . . . . 1.98 112.824 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -102.9 -43.57 5.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.912 0.387 . . . . 4.15 110.718 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -86.09 113.93 22.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.63 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -116.42 122.58 45.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 1.84 109.857 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HB3' HD11 ' A' ' 56' ' ' LEU . 36.9 tp -127.53 135.83 50.88 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.025 -0.27 . . . . 1.3 110.704 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -92.48 132.86 36.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.469 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.53 136.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.095 -0.502 . . . . 0.87 110.603 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.49 131.07 50.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.491 . . . . 1.86 110.578 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.71 111.56 23.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.55 -0.908 . . . . 1.13 108.55 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.624 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 38.7 mtp180 -123.99 159.49 56.21 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.699 -0.228 . . . . 2.19 110.825 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.11 146.97 53.27 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.266 1.977 . . . . 1.08 111.017 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 27' ' ' PRO . 4.6 ttt -76.98 60.76 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 1.68 110.184 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.71 35.98 26.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.217 -0.901 . . . . 2.12 111.105 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.26 -35.55 9.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.709 -0.678 . . . . 2.44 111.536 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.432 ' CB ' ' HE1' ' A' ' 92' ' ' TRP . 24.2 m -154.25 -178.94 7.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.54 0.21 . . . . 1.25 110.928 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.62 117.22 33.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 1.42 110.607 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 10.5 m95 -119.05 144.59 46.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.98 110.535 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.7 m -74.4 122.75 23.47 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 109.603 -0.518 . . . . 1.06 109.603 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -84.17 128.03 34.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.166 -0.924 . . . . 1.03 112.434 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 21.2 t70 -137.45 146.61 44.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.802 -1.09 . . . . 1.18 108.52 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -75.7 2.57 11.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.587 0.232 . . . . 1.54 111.422 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 52' ' ' GLY . . . -132.4 -53.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.566 -0.826 . . . . 0.8 112.996 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 41.9 t -127.41 121.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 1.06 110.653 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' CZ ' ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -93.37 130.94 38.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 1.27 109.456 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 36.8 p90 -153.23 149.33 27.85 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 119.916 -0.713 . . . . 1.14 112.146 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 22.9 pttt -95.71 143.24 27.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 1.32 110.813 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -27.63 42.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 2.29 110.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.75 131.04 45.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.748 -0.66 . . . . 2.28 110.913 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.8 m -81.27 164.07 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.321 -0.4 . . . . 1.94 110.722 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.47 159.55 27.99 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.882 -0.675 . . . . 1.52 111.608 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 170.74 1.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.167 0.508 . . . . 1.65 111.133 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HE1' ' CB ' ' A' ' 75' ' ' SER . 6.2 t90 -137.43 142.7 41.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.492 -0.322 . . . . 1.38 110.608 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.18 96.46 0.17 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.423 -0.671 . . . . 1.5 111.423 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.85 -150.68 5.81 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.097 -1.049 . . . . 1.1 112.549 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.21 129.95 52.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.588 0.232 . . . . 1.31 110.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 pt -108.89 154.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.977 -0.379 . . . . 0.93 109.977 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.62 157.71 24.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.941 -0.647 . . . . 0.93 111.535 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -93.86 121.05 44.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.601 -0.518 . . . . 1.03 109.601 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ARG . 84.0 m-85 -117.25 136.39 53.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.897 -0.409 . . . . 1.16 109.897 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 19' ' ' LEU . 6.2 p -81.86 144.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.909 0.385 . . . . 1.17 111.294 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.05 100.75 13.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.378 -0.971 . . . . 1.26 108.378 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.2 136.04 1.53 Allowed Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.305 -0.718 . . . . 1.33 111.305 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 130.04 42.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 1.94 110.464 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.495 ' OE1' HD13 ' A' ' 65' ' ' LEU . 23.0 tp60 -82.67 -14.6 54.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 1.8 112.699 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.13 20.87 10.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.194 0.521 . . . . 1.83 110.734 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.3 t30 57.41 52.61 8.42 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.46 -0.791 . . . . 1.89 112.674 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.52 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 3.2 m -64.06 133.11 95.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.183 -0.673 . . . . 2.0 109.183 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -32.82 103.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.273 3.315 . . . . 1.89 114.009 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.617 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 98.3 Cg_endo -89.98 -164.39 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.125 2.55 . . . . 1.68 113.327 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.57 -92.34 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.804 -0.918 . . . . 1.58 110.804 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.89 115.63 10.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.529 -0.545 . . . . 1.64 109.529 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 109' ' ' PRO . 50.2 m-85 -124.98 129.73 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 1.44 110.489 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -113.04 125.6 54.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.294 -0.412 . . . . 1.25 110.076 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.3 OUTLIER -129.48 106.89 9.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.229 0.537 . . . . 0.95 110.101 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.5 m -85.55 118.28 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 1.04 110.971 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.8 mt -111.87 127.38 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.503 -0.554 . . . . 0.8 109.503 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -116.07 133.76 55.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.16 0.505 . . . . 0.94 110.881 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.17 162.27 27.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.591 -0.814 . . . . 0.9 112.093 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.42 -156.5 27.02 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.818 -0.913 . . . . 0.92 110.818 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -113.0 172.93 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.176 -0.609 . . . . 1.46 111.359 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 127' ' ' GLN . 18.4 t-105 -133.0 146.68 51.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.211 -0.904 . . . . 1.15 109.648 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -117.77 131.94 56.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.816 0.341 . . . . 1.3 111.47 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 tttm 58.61 -118.12 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.43 -0.805 . . . . 1.63 111.597 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HA ' ' HE1' ' A' ' 121' ' ' TRP . 3.2 p-10 -175.18 150.08 1.13 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.398 0.279 . . . . 1.44 110.392 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 65.0 -36.86 0.21 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.337 1.236 . . . . 1.46 114.337 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -64.25 -13.72 51.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 1.58 112.873 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.553 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 31.4 mt-30 69.05 39.6 1.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.006 0.431 . . . . 1.4 112.002 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.49 69.81 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 1.16 110.834 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -105.84 145.87 30.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.061 0.458 . . . . 1.08 111.656 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.3 m -137.82 116.8 9.89 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 1.26 109.813 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.49 105.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.591 2.194 . . . . 1.13 112.615 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.81 124.73 42.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.73 -0.668 . . . . 1.18 110.622 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.73 -126.52 5.52 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.633 -0.794 . . . . 1.24 112.141 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 146.33 42.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.774 0.321 . . . . 1.33 110.86 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 t -103.66 136.56 43.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.637 -0.875 . . . . 1.11 108.637 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.5 116.6 3.84 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.678 -0.772 . . . . 0.96 112.255 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.39 108.65 20.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.722 -0.473 . . . . 1.14 109.722 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.412 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 8.2 m -92.34 125.59 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.469 -0.567 . . . . 1.02 109.469 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -108.76 125.38 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.442 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 53.0 tp -102.18 108.61 20.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.375 -0.83 . . . . 1.36 108.965 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 3.4 m -117.92 134.05 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.419 . . . . 1.6 110.472 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.2 126.13 44.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.112 0.482 . . . . 1.71 110.113 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 5.9 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.73 -0.652 . . . . 2.03 109.841 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 1' ' ' LYS . . . . . . . . . . . . . 30.0 ttpp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.103 -0.332 . . . . 3.18 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 2' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.47 122.48 9.8 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.555 0.534 . . . . 2.28 109.828 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 3' ' ' THR . . . . . . . . . . . . . 10.0 m -119.11 131.11 55.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.826 0.346 . . . . 2.53 111.818 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 4' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 127.06 64.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.305 -0.628 . . . . 2.33 109.305 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.16 145.54 49.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.009 0.433 . . . . 2.87 110.317 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.5 120.62 42.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.892 -0.595 . . . . 2.72 110.187 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 7' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' N' ' 8' ' ' PRO . 2.3 t -128.28 114.52 19.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.993 0.425 . . . . 2.77 110.492 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 8' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' N' ' 7' ' ' THR . 98.2 Cg_endo -81.54 166.45 72.75 Favored 'Cis proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.449 -1.479 . . . . 3.1 112.307 -0.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -77.59 -36.72 51.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.4 -0.593 . . . . 3.52 109.4 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -104.24 93.3 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.284 -0.871 . . . . 3.93 109.189 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' N' ' 106' ' ' VAL . 0.7 OUTLIER -91.57 151.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.196 -0.456 . . . . 3.41 110.762 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' N' N ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 150.22 26.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.375 -0.375 . . . . 3.67 110.29 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 13' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.72 116.39 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.115 -0.493 . . . . 4.04 110.774 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 13.26 18.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.016 -0.612 . . . . 3.36 112.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -125.88 -172.72 2.67 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.908 -0.172 . . . . 3.79 110.709 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.21 154.61 36.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 2.81 111.367 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 17' ' ' VAL . . . . . 0.419 HG12 HD11 ' N' ' 78' ' ' ILE . 13.1 p -127.77 135.05 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.643 -0.503 . . . . 2.4 109.643 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -105.48 111.78 24.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.969 0.414 . . . . 2.19 110.701 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 19' ' ' LEU . . . . . . . . . . . . . 58.0 mt -87.98 91.92 8.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.573 -0.899 . . . . 2.0 108.573 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 20' ' ' LEU . . . . . . . . . . . . . 51.5 mt -78.11 136.04 37.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 2.26 111.738 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.55 124.44 60.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.423 -0.808 . . . . 1.81 110.227 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 22' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -113.04 147.38 37.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.387 -0.37 . . . . 2.44 110.878 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 23' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 64.45 55.55 1.36 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.01 0.819 . . . . 2.75 111.69 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 24' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' N' ' 25' ' ' PRO . 17.9 tp -77.8 130.6 72.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 2.05 110.22 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 25' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' N' ' 24' ' ' LEU . 60.0 Cg_endo -72.6 -170.56 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.951 2.434 . . . . 2.04 113.232 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 26' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -109.01 179.87 4.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.021 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 46.99 15.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.027 -0.533 . . . . 3.18 110.904 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 28' ' ' LEU . . . . . 0.482 ' H ' HD22 ' N' ' 28' ' ' LEU . 2.2 mm? -71.55 126.37 29.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 2.25 111.263 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -105.76 -35.25 7.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.961 -0.563 . . . . 2.28 109.536 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.91 143.81 4.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.862 -0.685 . . . . 1.47 112.35 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 31' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -97.72 143.52 28.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.761 -0.829 . . . . 1.42 108.761 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 32' ' ' SER . . . . . . . . . . . . . 46.8 m -138.92 118.52 13.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.732 -0.387 . . . . 1.27 111.114 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 33' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -98.67 130.47 45.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.129 -0.487 . . . . 1.41 110.089 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -122.24 155.25 36.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 1.47 110.488 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -96.81 98.92 10.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.949 -0.389 . . . . 2.34 109.949 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 -155.35 26.27 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.978 -0.63 . . . . 1.97 111.848 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -116.4 9.22 14.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.661 0.23 . . . . 2.86 111.55 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' N' ' 38' ' ' ARG . 3.0 ptt180 -146.34 170.34 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 5.58 111.04 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 p -85.66 89.29 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.092 -0.504 . . . . 2.01 111.341 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.83 -155.89 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 2.7 109.994 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.9 -32.13 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.115 -0.794 . . . . 2.33 111.115 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 42' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.78 -16.91 34.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.313 0.577 . . . . 2.72 109.799 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 m -115.27 41.13 2.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 2.43 111.299 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.87 143.89 30.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 2.09 110.484 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 45' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' N' ' 61' ' ' TYR . 76.6 mt -93.21 -54.98 6.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.64 -0.504 . . . . 1.43 109.64 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -164.18 148.14 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.162 -0.615 . . . . 1.3 112.464 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.5 134.56 10.4 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.373 -1.091 . . . . 1.32 110.373 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 48' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' N' ' 55' ' ' ALA . 93.3 t80 -129.46 112.76 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.438 0.533 . . . . 1.76 112.438 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 49' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.4 105.32 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.515 -0.92 . . . . 1.76 108.515 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 50' ' ' ILE . . . . . 0.421 ' H ' HD12 ' N' ' 50' ' ' ILE . 0.7 OUTLIER -58.43 -46.89 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.135 0.791 . . . . 1.9 113.135 -177.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' N' N ' 51' ' ' GLY . . . . . . . . . . . . . . . -44.19 -44.06 7.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.907 0.723 . . . . 2.31 114.907 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 52' ' ' THR . . . . . 0.591 HG21 ' H93' ' N' 1113 ' ' MTN . 0.7 OUTLIER -119.84 7.37 10.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.211 0.505 . . . . 2.53 111.526 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' N' N ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 59.79 26.32 15.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.414 0.626 . . . . 2.92 110.021 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.94 102.37 8.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.285 -0.87 . . . . 1.85 110.534 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 55' ' ' ALA . . . . . 0.439 ' HB2' ' HD1' ' N' ' 48' ' ' TYR . . . -105.3 129.46 53.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.646 0.26 . . . . 1.48 110.334 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.12 126.22 25.62 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.533 -0.303 . . . . 1.77 110.301 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 146.72 45.56 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.767 2.312 . . . . 1.8 112.896 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.62 -177.77 24.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.98 -0.628 . . . . 1.69 111.627 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 59' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.64 -28.85 77.19 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.803 2.336 . . . . 2.0 112.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.0 8.96 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 1.84 111.885 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 61' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' N' ' 45' ' ' ILE . 86.5 t80 -74.66 116.4 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.95 -0.389 . . . . 2.04 109.95 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 62' ' ' SER . . . . . . . . . . . . . 34.4 p -91.37 -32.02 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 2.39 111.138 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.16 9.58 17.64 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.766 -0.731 . . . . 2.29 111.792 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 64' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' N' ' 75' ' ' ILE . 24.1 mtm180 -112.33 -1.11 15.2 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.458 -0.571 . . . . 2.49 109.458 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.11 116.9 25.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.072 -0.967 . . . . 1.85 111.82 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 66' ' ' ILE . . . . . . . . . . . . . 42.7 mt -112.57 114.09 46.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.5 -0.773 . . . . 2.18 109.125 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -97.42 142.35 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.128 0.49 . . . . 1.46 111.393 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 68' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.81 160.24 37.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 2.09 110.276 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 69' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.78 -14.08 30.02 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.945 2.43 . . . . 1.71 113.281 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -94.63 13.7 23.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 1.78 110.293 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 71' ' ' ALA . . . . . . . . . . . . . . . 73.66 -4.3 2.27 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.064 0.946 . . . . 1.28 113.349 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -70.99 145.21 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.807 0.336 . . . . 1.67 110.737 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.39 121.91 38.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.362 0.601 . . . . 1.68 111.896 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.5 114.97 29.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.303 -0.628 . . . . 2.16 109.303 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 75' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' N' ' 78' ' ' ILE . 17.5 mt -107.11 119.24 56.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.976 -0.379 . . . . 2.27 109.976 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 76' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -96.9 167.62 10.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.212 -0.449 . . . . 3.31 110.68 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.24 53.05 12.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.423 0.63 . . . . 3.19 110.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 78' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' N' ' 75' ' ' ILE . 27.2 mm -65.41 132.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.413 -0.812 . . . . 3.1 111.505 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 pt -112.68 179.3 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.599 -0.728 . . . . 3.17 110.166 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -68.51 -29.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.798 0.332 . . . . 3.84 111.679 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 81' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -74.47 -6.25 47.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 3.15 111.624 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -81.52 -19.46 42.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 2.8 110.561 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 83' ' ' THR . . . . . 0.826 HG23 ' HA ' ' N' ' 105' ' ' ARG . 12.0 m -59.47 116.63 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.815 -0.63 . . . . 3.25 110.368 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.45 -154.06 25.17 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.774 -1.203 . . . . 2.79 113.206 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -109.2 148.98 30.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.23 0.538 . . . . 3.08 111.636 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 86' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.6 141.62 50.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.205 -0.907 . . . . 2.12 108.599 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 53.6 m -123.52 137.7 54.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.235 0.54 . . . . 1.96 112.308 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 88' ' ' LEU . . . . . . . . . . . . . 23.8 tp -113.27 135.57 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.461 -0.791 . . . . 1.45 110.583 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 89' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -113.82 122.12 46.08 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.992 -1.114 . . . . 1.93 107.992 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 90' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' N' ' 97' ' ' ASN . 42.1 t -98.73 90.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.139 -0.624 . . . . 1.56 110.994 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 mm -67.92 117.06 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.814 -0.63 . . . . 1.62 109.733 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 92' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -121.36 153.02 38.33 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.507 -0.769 . . . . 2.24 109.907 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.05 34.95 0.25 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 2.63 110.782 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 94' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' N' ' 95' ' ' LEU . 4.2 t70 -141.4 19.3 2.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.943 -0.571 . . . . 3.1 110.604 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 95' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' N' ' 94' ' ' ASP . 50.7 mt 73.91 -38.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.387 0.675 . . . . 3.49 112.496 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 96' ' ' VAL . . . . . 0.534 HG12 ' HG3' ' N' ' 98' ' ' GLU . 12.2 t -69.46 93.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 2.55 110.052 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 97' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' N' ' 90' ' ' VAL . 81.8 m-20 -97.44 40.81 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.787 -0.642 . . . . 2.01 112.111 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 98' ' ' GLU . . . . . 0.534 ' HG3' HG12 ' N' ' 96' ' ' VAL . 13.6 mt-10 -12.82 116.65 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.295 1.438 . . . . 2.22 114.375 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -103.3 143.65 32.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.25 -0.886 . . . . 2.32 111.108 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.53 149.16 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 1.94 110.007 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 101' ' ' THR . . . . . . . . . . . . . 36.3 m -126.48 136.48 52.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.083 0.468 . . . . 2.35 111.849 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.79 171.79 20.21 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.058 -1.217 . . . . 2.32 110.058 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -154.96 159.56 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.112 0.956 . . . . 3.42 111.879 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 104' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.33 164.47 38.55 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.649 -0.705 . . . . 2.93 109.745 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 105' ' ' ARG . . . . . 0.826 ' HA ' HG23 ' N' ' 83' ' ' THR . 75.8 mtt180 -124.87 149.57 47.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 3.95 110.9 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 106' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' N' ' 11' ' ' VAL . 13.8 t -118.93 139.65 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 3.67 111.081 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 107' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.11 147.62 67.02 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 4.25 110.167 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.98 149.74 20.32 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.602 2.201 . . . . 4.34 112.488 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -117.44 137.63 52.38 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.719 -0.475 . . . . 4.53 109.719 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.16 -0.924 . . . . 4.99 110.149 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N 1111 ' ' MTN . . . . . 0.497 ' H91' ' SD ' ' A' ' 72' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N 1112 ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N 1113 ' ' MTN . . . . . 0.591 ' H93' HG21 ' N' ' 52' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.753 0.311 . . . . 2.16 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -156.56 169.98 23.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.748 -0.464 . . . . 1.88 109.748 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 94.02 0.56 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.26 0.35 . . . . 1.33 110.439 179.75 -67.354 -128.217 110.158 103.009 2.028 103.876 43.455 -98.896 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -103.51 121.92 43.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.012 0.434 . . . . 1.68 110.496 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -111.99 122.07 65.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.792 . . . . 1.03 108.86 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 -91.85 103.91 16.4 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.468 -0.493 . . . . 4.04 111.45 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 t -99.7 128.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.489 -0.93 . . . . 1.12 108.489 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.6 150.48 19.36 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.381 -0.914 . . . . 1.19 113.663 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.39 149.92 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.705 -0.479 . . . . 2.14 109.705 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 mt -154.8 126.88 7.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.116 0.484 . . . . 2.53 112.041 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.3 m -114.78 120.72 41.0 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.618 -0.882 . . . . 1.91 108.618 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -137.14 150.82 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.943 0.401 . . . . 1.8 110.981 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 141' ' ' THR . . . -96.8 112.48 24.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.287 -0.87 . . . . 1.62 110.277 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.445 ' HE3' HD12 ' A' ' 25' ' ' ILE . 11.6 pttt -158.66 156.01 29.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.147 -0.479 . . . . 3.14 110.595 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.75 164.47 13.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.891 -0.595 . . . . 1.79 110.724 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 107' ' ' THR . 35.9 mtp180 -76.44 -12.29 60.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.163 0.506 . . . . 1.5 110.068 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.25 -18.1 63.32 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.619 -0.719 . . . . 1.66 112.146 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -72.4 -18.97 61.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.618 0.723 . . . . 1.79 109.185 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 100' ' ' VAL . 3.7 mm? -81.95 73.01 9.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.09 -0.959 . . . . 1.42 110.619 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 t -87.55 95.23 9.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.881 -0.6 . . . . 1.72 110.322 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 t70 60.23 -95.71 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.558 -0.747 . . . . 1.52 110.099 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.42 95.11 5.36 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.248 0.547 . . . . 1.38 109.944 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.19 107.17 27.79 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.476 -0.784 . . . . 1.36 109.828 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.41 98.76 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.636 1.557 . . . . 1.41 111.236 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.445 HD12 ' HE3' ' A' ' 14' ' ' LYS . 5.1 pt -90.29 72.33 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.676 -0.693 . . . . 1.55 111.539 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.08 116.29 3.99 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.749 -0.738 . . . . 1.43 112.385 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.534 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 48.0 Cg_endo -88.29 115.93 0.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.628 2.218 . . . . 1.78 112.09 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.61 112.41 34.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.281 -0.418 . . . . 1.02 110.605 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 96.42 2.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.19 -0.459 . . . . 1.5 110.379 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.75 133.89 57.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.681 0.753 . . . . 1.39 111.692 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -126.03 141.02 52.14 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.901 -1.045 . . . . 2.47 108.871 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.72 127.38 53.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.902 0.382 . . . . 1.26 111.26 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.2 125.56 36.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.661 -0.699 . . . . 2.39 109.367 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.35 -147.16 19.94 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.747 -0.739 . . . . 1.39 111.651 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 38' ' ' ARG . 1.2 m 56.27 63.2 2.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.489 . . . . 1.38 111.266 -179.732 -98.896 43.455 110.158 103.876 2.028 103.009 -128.217 -67.354 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.61 -30.44 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.139 0.495 . . . . 1.95 109.839 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.31 13.64 5.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.698 -0.683 . . . . 1.72 110.963 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 3.8 tpp180 -114.9 155.0 27.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.312 -0.404 . . . . 1.86 110.03 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.61 132.54 34.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.335 -0.393 . . . . 1.5 110.912 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.85 135.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.869 -0.789 . . . . 1.01 108.869 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . . . -141.43 151.39 43.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 113.281 0.845 . . . . 0.79 113.281 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 mt -114.85 130.28 56.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.977 -1.01 . . . . 0.7 109.123 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 137.83 43.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.83 109.896 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.06 152.43 25.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.884 0.373 . . . . 0.8 111.029 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.22 158.64 5.13 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.592 -0.731 . . . . 1.21 110.273 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -61.41 -19.86 62.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.394 0.516 . . . . 1.29 112.394 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.06 -15.68 55.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.047 0.451 . . . . 1.63 110.2 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 114' ' ' LEU . 16.0 m120 -121.84 7.94 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.556 -0.747 . . . . 0.99 110.52 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 52' ' ' GLY . 62.7 t80 -136.73 118.62 15.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.411 -0.359 . . . . 1.09 110.105 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.19 143.5 36.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.507 . . . . 1.69 110.344 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 54.86 35.15 23.64 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.989 0.423 . . . . 1.66 111.756 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . 68.48 30.7 73.24 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.894 -0.669 . . . . 1.05 113.018 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 40.2 mmtm -135.97 142.65 44.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.212 -0.292 . . . . 1.25 110.212 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HD2' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -105.69 138.06 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.76 110.714 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -154.1 164.72 38.03 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.259 0.552 . . . . 1.16 111.616 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 65' ' ' LEU . 3.2 pp -104.84 145.74 29.96 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.326 -0.99 . . . . 1.04 108.326 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG1' ' HA ' ' A' ' 61' ' ' ASN . 8.6 tp -127.4 152.53 35.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.402 -0.363 . . . . 1.3 110.999 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -178.78 4.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 1.42 110.457 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -67.13 -32.52 73.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 2.2 111.878 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.4 -4.2 59.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.657 0.265 . . . . 2.81 111.625 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' CG1' ' A' ' 57' ' ' ILE . 46.5 m-80 57.63 27.47 14.28 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.824 0.675 . . . . 1.98 112.824 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -102.9 -43.57 5.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.912 0.387 . . . . 4.15 110.718 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -86.09 113.93 22.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.63 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -116.42 122.58 45.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.081 -0.509 . . . . 1.84 109.857 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HB3' HD11 ' A' ' 56' ' ' LEU . 36.9 tp -127.53 135.83 50.88 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 121.025 -0.27 . . . . 1.3 110.704 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -92.48 132.86 36.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.408 -0.36 . . . . 1.71 110.469 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.53 136.98 57.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.095 -0.502 . . . . 0.87 110.603 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.49 131.07 50.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.119 -0.491 . . . . 1.86 110.578 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.71 111.56 23.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.55 -0.908 . . . . 1.13 108.55 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.624 ' HG2' ' CZ ' ' A' ' 84' ' ' PHE . 38.7 mtp180 -123.99 159.49 56.21 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.699 -0.228 . . . . 2.19 110.825 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.11 146.97 53.27 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.266 1.977 . . . . 1.08 111.017 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 27' ' ' PRO . 4.6 ttt -76.98 60.76 1.86 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 1.68 110.184 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t0 57.71 35.98 26.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.217 -0.901 . . . . 2.12 111.105 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -101.26 -35.55 9.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.709 -0.678 . . . . 2.44 111.536 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.432 ' CB ' ' HE1' ' A' ' 92' ' ' TRP . 24.2 m -154.25 -178.94 7.46 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.54 0.21 . . . . 1.25 110.928 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.62 117.22 33.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 1.42 110.607 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 86' ' ' LYS . 10.5 m95 -119.05 144.59 46.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.98 110.535 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.7 m -74.4 122.75 23.47 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 109.603 -0.518 . . . . 1.06 109.603 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -84.17 128.03 34.31 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.166 -0.924 . . . . 1.03 112.434 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.597 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 21.2 t70 -137.45 146.61 44.53 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.802 -1.09 . . . . 1.18 108.52 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -75.7 2.57 11.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.587 0.232 . . . . 1.54 111.422 -179.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 52' ' ' GLY . . . -132.4 -53.6 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.566 -0.826 . . . . 0.8 112.996 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 80' ' ' ASP . 41.9 t -127.41 121.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 1.06 110.653 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' CZ ' ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -93.37 130.94 38.96 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 1.27 109.456 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 36.8 p90 -153.23 149.33 27.85 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 119.916 -0.713 . . . . 1.14 112.146 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 77' ' ' TRP . 22.9 pttt -95.71 143.24 27.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.934 0.397 . . . . 1.32 110.813 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -27.63 42.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.763 -0.653 . . . . 2.29 110.356 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.75 131.04 45.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.748 -0.66 . . . . 2.28 110.913 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 23.8 m -81.27 164.07 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.321 -0.4 . . . . 1.94 110.722 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.47 159.55 27.99 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.882 -0.675 . . . . 1.52 111.608 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -60.67 170.74 1.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.167 0.508 . . . . 1.65 111.133 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HE1' ' CB ' ' A' ' 75' ' ' SER . 6.2 t90 -137.43 142.7 41.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.492 -0.322 . . . . 1.38 110.608 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.18 96.46 0.17 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.423 -0.671 . . . . 1.5 111.423 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.85 -150.68 5.81 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.097 -1.049 . . . . 1.1 112.549 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.21 129.95 52.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.588 0.232 . . . . 1.31 110.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.1 pt -108.89 154.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.977 -0.379 . . . . 0.93 109.977 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.62 157.71 24.22 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.941 -0.647 . . . . 0.93 111.535 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.9 mp -93.86 121.05 44.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.601 -0.518 . . . . 1.03 109.601 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 70' ' ' ARG . 84.0 m-85 -117.25 136.39 53.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.897 -0.409 . . . . 1.16 109.897 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 19' ' ' LEU . 6.2 p -81.86 144.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.909 0.385 . . . . 1.17 111.294 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -88.05 100.75 13.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.378 -0.971 . . . . 1.26 108.378 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.2 136.04 1.53 Allowed Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.305 -0.718 . . . . 1.33 111.305 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.16 130.04 42.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 1.94 110.464 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.495 ' OE1' HD13 ' A' ' 65' ' ' LEU . 23.0 tp60 -82.67 -14.6 54.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 1.8 112.699 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.13 20.87 10.22 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.194 0.521 . . . . 1.83 110.734 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.3 t30 57.41 52.61 8.42 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.46 -0.791 . . . . 1.89 112.674 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.52 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 3.2 m -64.06 133.11 95.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.183 -0.673 . . . . 2.0 109.183 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -32.82 103.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.273 3.315 . . . . 1.89 114.009 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.617 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 98.3 Cg_endo -89.98 -164.39 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.125 2.55 . . . . 1.68 113.327 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -178.57 -92.34 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.804 -0.918 . . . . 1.58 110.804 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -138.89 115.63 10.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.529 -0.545 . . . . 1.64 109.529 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 109' ' ' PRO . 50.2 m-85 -124.98 129.73 50.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.793 0.33 . . . . 1.44 110.489 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 m -113.04 125.6 54.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.294 -0.412 . . . . 1.25 110.076 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' ' HB ' ' A' ' 138' ' ' THR . 0.3 OUTLIER -129.48 106.89 9.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.229 0.537 . . . . 0.95 110.101 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' THR . 1.5 m -85.55 118.28 24.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.828 -0.624 . . . . 1.04 110.971 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.8 mt -111.87 127.38 55.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.503 -0.554 . . . . 0.8 109.503 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -116.07 133.76 55.68 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.16 0.505 . . . . 0.94 110.881 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.17 162.27 27.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.591 -0.814 . . . . 0.9 112.093 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.42 -156.5 27.02 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.818 -0.913 . . . . 0.92 110.818 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -113.0 172.93 6.64 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.176 -0.609 . . . . 1.46 111.359 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 127' ' ' GLN . 18.4 t-105 -133.0 146.68 51.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.211 -0.904 . . . . 1.15 109.648 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -117.77 131.94 56.52 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.816 0.341 . . . . 1.3 111.47 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.7 tttm 58.61 -118.12 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.43 -0.805 . . . . 1.63 111.597 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HA ' ' HE1' ' A' ' 121' ' ' TRP . 3.2 p-10 -175.18 150.08 1.13 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 122.398 0.279 . . . . 1.44 110.392 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 65.0 -36.86 0.21 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.337 1.236 . . . . 1.46 114.337 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -64.25 -13.72 51.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 1.58 112.873 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.553 ' HA ' ' CH2' ' A' ' 121' ' ' TRP . 31.4 mt-30 69.05 39.6 1.74 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.006 0.431 . . . . 1.4 112.002 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -86.49 69.81 3.06 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.834 -0.906 . . . . 1.16 110.834 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -105.84 145.87 30.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.061 0.458 . . . . 1.08 111.656 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.3 m -137.82 116.8 9.89 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 1.26 109.813 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.49 105.49 1.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.591 2.194 . . . . 1.13 112.615 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.81 124.73 42.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.73 -0.668 . . . . 1.18 110.622 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.73 -126.52 5.52 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.633 -0.794 . . . . 1.24 112.141 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.37 146.33 42.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.774 0.321 . . . . 1.33 110.86 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 t -103.66 136.56 43.13 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.637 -0.875 . . . . 1.11 108.637 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.5 116.6 3.84 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.678 -0.772 . . . . 0.96 112.255 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.39 108.65 20.12 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.722 -0.473 . . . . 1.14 109.722 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.412 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 8.2 m -92.34 125.59 37.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.469 -0.567 . . . . 1.02 109.469 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -108.76 125.38 51.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.994 -0.548 . . . . 1.45 110.442 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 53.0 tp -102.18 108.61 20.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.375 -0.83 . . . . 1.36 108.965 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 3.4 m -117.92 134.05 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.419 . . . . 1.6 110.472 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.2 126.13 44.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.112 0.482 . . . . 1.71 110.113 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 13' ' ' ALA . 5.9 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.73 -0.652 . . . . 2.03 109.841 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 1' ' ' LYS . . . . . . . . . . . . . 30.0 ttpp . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 110.103 -0.332 . . . . 3.18 110.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 2' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.47 122.48 9.8 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.555 0.534 . . . . 2.28 109.828 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 3' ' ' THR . . . . . . . . . . . . . 10.0 m -119.11 131.11 55.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.826 0.346 . . . . 2.53 111.818 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 4' ' ' ILE . . . . . . . . . . . . . 30.4 mm -107.92 127.06 64.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.305 -0.628 . . . . 2.33 109.305 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.16 145.54 49.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.009 0.433 . . . . 2.87 110.317 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.5 120.62 42.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.892 -0.595 . . . . 2.72 110.187 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 7' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' N' ' 8' ' ' PRO . 2.3 t -128.28 114.52 19.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.993 0.425 . . . . 2.77 110.492 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 8' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' N' ' 7' ' ' THR . 98.2 Cg_endo -81.54 166.45 72.75 Favored 'Cis proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.449 -1.479 . . . . 3.1 112.307 -0.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -77.59 -36.72 51.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.4 -0.593 . . . . 3.52 109.4 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -104.24 93.3 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.284 -0.871 . . . . 3.93 109.189 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' N' ' 106' ' ' VAL . 0.7 OUTLIER -91.57 151.88 3.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.196 -0.456 . . . . 3.41 110.762 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' N' N ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.33 150.22 26.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.375 -0.375 . . . . 3.67 110.29 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 13' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.72 116.39 4.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.115 -0.493 . . . . 4.04 110.774 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 13.26 18.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.016 -0.612 . . . . 3.36 112.569 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 15' ' ' LYS . . . . . . . . . . . . . 17.6 mmtp -125.88 -172.72 2.67 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.908 -0.172 . . . . 3.79 110.709 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.21 154.61 36.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.806 0.336 . . . . 2.81 111.367 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 17' ' ' VAL . . . . . 0.419 HG12 HD11 ' N' ' 78' ' ' ILE . 13.1 p -127.77 135.05 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.643 -0.503 . . . . 2.4 109.643 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 18' ' ' LEU . . . . . . . . . . . . . 52.7 tp -105.48 111.78 24.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.969 0.414 . . . . 2.19 110.701 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 19' ' ' LEU . . . . . . . . . . . . . 58.0 mt -87.98 91.92 8.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.573 -0.899 . . . . 2.0 108.573 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 20' ' ' LEU . . . . . . . . . . . . . 51.5 mt -78.11 136.04 37.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 2.26 111.738 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.55 124.44 60.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.423 -0.808 . . . . 1.81 110.227 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 22' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -113.04 147.38 37.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.387 -0.37 . . . . 2.44 110.878 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m120 64.45 55.55 1.36 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.01 0.819 . . . . 2.75 111.69 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 24' ' ' LEU . . . . . 0.405 HD12 ' HD2' ' N' ' 25' ' ' PRO . 17.9 tp -77.8 130.6 72.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.845 -0.616 . . . . 2.05 110.22 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 25' ' ' PRO . . . . . 0.405 ' HD2' HD12 ' N' ' 24' ' ' LEU . 60.0 Cg_endo -72.6 -170.56 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.951 2.434 . . . . 2.04 113.232 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 26' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -109.01 179.87 4.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.021 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.95 46.99 15.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.027 -0.533 . . . . 3.18 110.904 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 28' ' ' LEU . . . . . 0.482 ' H ' HD22 ' N' ' 28' ' ' LEU . 2.2 mm? -71.55 126.37 29.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 2.25 111.263 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 29' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -105.76 -35.25 7.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.961 -0.563 . . . . 2.28 109.536 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.91 143.81 4.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.862 -0.685 . . . . 1.47 112.35 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 31' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -97.72 143.52 28.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.761 -0.829 . . . . 1.42 108.761 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 32' ' ' SER . . . . . . . . . . . . . 46.8 m -138.92 118.52 13.0 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.732 -0.387 . . . . 1.27 111.114 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 33' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -98.67 130.47 45.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.129 -0.487 . . . . 1.41 110.089 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -122.24 155.25 36.27 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 1.47 110.488 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -96.81 98.92 10.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.949 -0.389 . . . . 2.34 109.949 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 -155.35 26.27 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.978 -0.63 . . . . 1.97 111.848 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 37' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -116.4 9.22 14.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.661 0.23 . . . . 2.86 111.55 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' N' ' 38' ' ' ARG . 3.0 ptt180 -146.34 170.34 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 5.58 111.04 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 39' ' ' CYS . . . . . . . . . . . . . 9.4 p -85.66 89.29 7.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.092 -0.504 . . . . 2.01 111.341 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -86.83 -155.89 0.29 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.12 -0.491 . . . . 2.7 109.994 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.9 -32.13 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.115 -0.794 . . . . 2.33 111.115 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 42' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.78 -16.91 34.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.313 0.577 . . . . 2.72 109.799 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 m -115.27 41.13 2.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.777 -0.647 . . . . 2.43 111.299 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 44' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -82.87 143.89 30.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.417 -0.356 . . . . 2.09 110.484 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 45' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' N' ' 61' ' ' TYR . 76.6 mt -93.21 -54.98 6.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.64 -0.504 . . . . 1.43 109.64 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 46' ' ' ILE . . . . . . . . . . . . . 17.5 tt -164.18 148.14 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.162 -0.615 . . . . 1.3 112.464 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.5 134.56 10.4 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.373 -1.091 . . . . 1.32 110.373 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 48' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' N' ' 55' ' ' ALA . 93.3 t80 -129.46 112.76 14.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.438 0.533 . . . . 1.76 112.438 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 49' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.4 105.32 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.515 -0.92 . . . . 1.76 108.515 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 50' ' ' ILE . . . . . 0.421 ' H ' HD12 ' N' ' 50' ' ' ILE . 0.7 OUTLIER -58.43 -46.89 89.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.135 0.791 . . . . 1.9 113.135 -177.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' N' N ' 51' ' ' GLY . . . . . . . . . . . . . . . -44.19 -44.06 7.51 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 114.907 0.723 . . . . 2.31 114.907 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 52' ' ' THR . . . . . 0.591 HG21 ' H93' ' N' 1113 ' ' MTN . 0.7 OUTLIER -119.84 7.37 10.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 117.211 0.505 . . . . 2.53 111.526 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' N' N ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 59.79 26.32 15.47 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.414 0.626 . . . . 2.92 110.021 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.94 102.37 8.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.285 -0.87 . . . . 1.85 110.534 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 55' ' ' ALA . . . . . 0.439 ' HB2' ' HD1' ' N' ' 48' ' ' TYR . . . -105.3 129.46 53.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.646 0.26 . . . . 1.48 110.334 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.12 126.22 25.62 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.533 -0.303 . . . . 1.77 110.301 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.38 146.72 45.56 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.767 2.312 . . . . 1.8 112.896 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.62 -177.77 24.88 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.98 -0.628 . . . . 1.69 111.627 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 59' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.64 -28.85 77.19 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.803 2.336 . . . . 2.0 112.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.0 8.96 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 1.84 111.885 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 61' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' N' ' 45' ' ' ILE . 86.5 t80 -74.66 116.4 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.95 -0.389 . . . . 2.04 109.95 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 62' ' ' SER . . . . . . . . . . . . . 34.4 p -91.37 -32.02 15.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.791 0.329 . . . . 2.39 111.138 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.16 9.58 17.64 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.766 -0.731 . . . . 2.29 111.792 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 64' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' N' ' 75' ' ' ILE . 24.1 mtm180 -112.33 -1.11 15.2 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.458 -0.571 . . . . 2.49 109.458 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 65' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.11 116.9 25.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.072 -0.967 . . . . 1.85 111.82 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 66' ' ' ILE . . . . . . . . . . . . . 42.7 mt -112.57 114.09 46.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.5 -0.773 . . . . 2.18 109.125 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tp -97.42 142.35 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.128 0.49 . . . . 1.46 111.393 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 68' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -116.81 160.24 37.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 2.09 110.276 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 69' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.78 -14.08 30.02 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.945 2.43 . . . . 1.71 113.281 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 70' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -94.63 13.7 23.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 1.78 110.293 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 71' ' ' ALA . . . . . . . . . . . . . . . 73.66 -4.3 2.27 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.064 0.946 . . . . 1.28 113.349 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -70.99 145.21 50.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.807 0.336 . . . . 1.67 110.737 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.39 121.91 38.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.362 0.601 . . . . 1.68 111.896 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 74' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.5 114.97 29.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.303 -0.628 . . . . 2.16 109.303 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 75' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' N' ' 78' ' ' ILE . 17.5 mt -107.11 119.24 56.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.976 -0.379 . . . . 2.27 109.976 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 76' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -96.9 167.62 10.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.212 -0.449 . . . . 3.31 110.68 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 53.24 53.05 12.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.423 0.63 . . . . 3.19 110.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 78' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' N' ' 75' ' ' ILE . 27.2 mm -65.41 132.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.413 -0.812 . . . . 3.1 111.505 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 79' ' ' ILE . . . . . . . . . . . . . 29.8 pt -112.68 179.3 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.599 -0.728 . . . . 3.17 110.166 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -68.51 -29.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.798 0.332 . . . . 3.84 111.679 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 81' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -74.47 -6.25 47.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 3.15 111.624 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -81.52 -19.46 42.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 2.8 110.561 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 83' ' ' THR . . . . . 0.826 HG23 ' HA ' ' N' ' 105' ' ' ARG . 12.0 m -59.47 116.63 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.815 -0.63 . . . . 3.25 110.368 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.45 -154.06 25.17 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.774 -1.203 . . . . 2.79 113.206 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 85' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -109.2 148.98 30.06 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.23 0.538 . . . . 3.08 111.636 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 86' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -130.6 141.62 50.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.205 -0.907 . . . . 2.12 108.599 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 87' ' ' THR . . . . . . . . . . . . . 53.6 m -123.52 137.7 54.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.235 0.54 . . . . 1.96 112.308 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 88' ' ' LEU . . . . . . . . . . . . . 23.8 tp -113.27 135.57 53.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.461 -0.791 . . . . 1.45 110.583 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 89' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -113.82 122.12 46.08 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.992 -1.114 . . . . 1.93 107.992 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 90' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' N' ' 97' ' ' ASN . 42.1 t -98.73 90.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.139 -0.624 . . . . 1.56 110.994 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 91' ' ' ILE . . . . . . . . . . . . . 22.4 mm -67.92 117.06 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.814 -0.63 . . . . 1.62 109.733 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 92' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -121.36 153.02 38.33 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.507 -0.769 . . . . 2.24 109.907 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.05 34.95 0.25 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 2.63 110.782 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 94' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' N' ' 95' ' ' LEU . 4.2 t70 -141.4 19.3 2.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.943 -0.571 . . . . 3.1 110.604 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 95' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' N' ' 94' ' ' ASP . 50.7 mt 73.91 -38.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.387 0.675 . . . . 3.49 112.496 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 96' ' ' VAL . . . . . 0.534 HG12 ' HG3' ' N' ' 98' ' ' GLU . 12.2 t -69.46 93.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 2.55 110.052 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 97' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' N' ' 90' ' ' VAL . 81.8 m-20 -97.44 40.81 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.787 -0.642 . . . . 2.01 112.111 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 98' ' ' GLU . . . . . 0.534 ' HG3' HG12 ' N' ' 96' ' ' VAL . 13.6 mt-10 -12.82 116.65 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.295 1.438 . . . . 2.22 114.375 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -103.3 143.65 32.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.25 -0.886 . . . . 2.32 111.108 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.53 149.16 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 1.94 110.007 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 101' ' ' THR . . . . . . . . . . . . . 36.3 m -126.48 136.48 52.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.083 0.468 . . . . 2.35 111.849 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.79 171.79 20.21 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.058 -1.217 . . . . 2.32 110.058 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.96 159.56 40.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.112 0.956 . . . . 3.42 111.879 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 104' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.33 164.47 38.55 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.649 -0.705 . . . . 2.93 109.745 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 105' ' ' ARG . . . . . 0.826 ' HA ' HG23 ' N' ' 83' ' ' THR . 75.8 mtt180 -124.87 149.57 47.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.476 -0.329 . . . . 3.95 110.9 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 106' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' N' ' 11' ' ' VAL . 13.8 t -118.93 139.65 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 3.67 111.081 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 107' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.11 147.62 67.02 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.306 -0.406 . . . . 4.25 110.167 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 108' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.98 149.74 20.32 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.602 2.201 . . . . 4.34 112.488 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -117.44 137.63 52.38 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.719 -0.475 . . . . 4.53 109.719 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.16 -0.924 . . . . 4.99 110.149 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N 1111 ' ' MTN . . . . . 0.497 ' H91' ' SD ' ' A' ' 72' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N 1112 ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N 1113 ' ' MTN . . . . . 0.591 ' H93' HG21 ' N' ' 52' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_